Creative Medical Technology (CELZ) Rockets 674% on Big News – Own Snap

There were numerous stocks that recorded gains on Tuesday but the gains made by Creative Medical Technology Holdings Inc (OTC: CELZ) were particularly eye-catching.

The stock soared by as much as 675% after the company released data and also filed a patent with regards to its product ImmeCelz. The product in question is meant for reversing liver failure and the data revealed that it had the ability to do so in a carbon tetrachloride preclinical model.

That proved to be a major trigger for the CELZ stock and investors soon piled on to it. It goes without saying that it is a major development for the company and it remains to be seen if the stock can continue to add to its gains through the rest of the week.

The company holds a range of patents when it comes to cellular therapy and the one related to ImmeCelz is the latest.

Editor and Computer Expert

A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.

Read more here:
Creative Medical Technology (CELZ) Rockets 674% on Big News - Own Snap